ALLMedicine™ Type 2 Diabetes In Children Center
Research & Reviews 121 results
https://doi.org/10.1111/obr.13177
Obesity Reviews : an Official Journal of the Internationa... Chadda KR, Cheng TS et. al.
Dec 23rd, 2020 - Pharmacological options for management of obesity and type 2 diabetes mellitus (T2DM) in children are limited. We aimed to synthesize published randomized controlled trial (RCT) evidence on the efficacy of glucagon-like peptide-1 (GLP-1) agonists ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489393
JAMA Psychiatry; Sun JW, Hernández-Díaz S et. al.
Sep 2nd, 2020 - Concerns exist that use of selective serotonin reuptake inhibitors (SSRIs) increases the risk of developing type 2 diabetes (T2D) in adults, but evidence in children and adolescents is limited. In the absence of a randomized clinical trial, eviden...
https://clinicaltrials.gov/ct2/show/NCT03323294
Feb 16th, 2020 - The investigators want to learn more about obesity, the development of insulin resistance, and Type 2 Diabetes in children. The investigators will do this through collecting information about children's health and conducting experiments on a varie...
https://www.mdedge.com/pediatrics/article/214278/diabetes/could-liraglutide-stall-onset-type-2-diabetes-children?channel=39313
Doug Brunk
Dec 13th, 2019 - LOS ANGELES – Until the recent approval of liraglutide for the treatment of children and adolescents with type 2 diabetes, investigators like Sonia Caprio, MD, were at their wits’ end watching the beta-cell function of their patients decline on me.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079233
Pediatric Obesity; Koutny F, Weghuber D et. al.
Dec 6th, 2019 - Non-alcoholic fatty liver disease (NAFLD), prediabetes and type 2 diabetes mellitus are known to be closely linked with obesity as early as during childhood. The study aimed to determine the prevalence of prediabetes and T2DM in children with obes...
Guidelines 23 results
http://care.diabetesjournals.org/content/42/Supplement_1/S148
Dec 18th, 2018 - The management of diabetes in children and adolescents cannot simply be derived from care routinely provided to adults with diabetes. The epidemiology, pathophysiology, developmental considerations, and response to therapy in pediatric-onset diabe...
http://care.diabetesjournals.org/content/42/Supplement_1/S13
Dec 18th, 2018 - Type 1 diabetes and type 2 diabetes are heterogeneous diseases in which clinical presentation and disease progression may vary considerably. Classification is important for determining therapy, but some individuals cannot be clearly classified as ...
http://care.diabetesjournals.org/content/42/Supplement_1/S7
Dec 18th, 2018 - Population health is defined as “the health outcomes of a group of individuals, including the distribution of health outcomes within the group”; these outcomes can be measured in terms of health outcomes (mortality, morbidity, health, and function...
http://care.diabetesjournals.org/content/42/Supplement_1/S29
Dec 18th, 2018 - Screening for prediabetes and type 2 diabetes risk through an informal assessment of risk factors (Table 2.3) or with an assessment tool, such as the American Diabetes Association risk test (Fig. 2.1), is recommended to guide providers on whether ...
http://care.diabetesjournals.org/content/42/Supplement_1/S4
Dec 18th, 2018 - The field of diabetes care is rapidly changing as new research, technology, and treatments that can improve the health and well-being of people with diabetes continue to emerge. With annual updates since 1989, the American Diabetes Association (AD...
Drugs 7 results see all →
Clinicaltrials.gov 171 results
https://www.medscape.com/viewarticle/945406
Feb 7th, 2021 - NEW YORK (Reuters Health) - The first genome-wide association study (GWAS) of type 2 diabetes in young people identified genes already known in adults as well as novel variants, researchers say. "This suggests that type 2 diabetes in children has ...
https://doi.org/10.1111/obr.13177
Obesity Reviews : an Official Journal of the Internationa... Chadda KR, Cheng TS et. al.
Dec 23rd, 2020 - Pharmacological options for management of obesity and type 2 diabetes mellitus (T2DM) in children are limited. We aimed to synthesize published randomized controlled trial (RCT) evidence on the efficacy of glucagon-like peptide-1 (GLP-1) agonists ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489393
JAMA Psychiatry; Sun JW, Hernández-Díaz S et. al.
Sep 2nd, 2020 - Concerns exist that use of selective serotonin reuptake inhibitors (SSRIs) increases the risk of developing type 2 diabetes (T2D) in adults, but evidence in children and adolescents is limited. In the absence of a randomized clinical trial, eviden...
https://www.mayoclinic.org/diseases-conditions/type-2-diabetes-in-children/diagnosis-treatment/drc-20355324
Aug 25th, 2020 - Diagnosis If diabetes is suspected, your child's doctor will likely recommend a screening test. A diagnosis of type 2 diabetes in children generally requires abnormal results from two tests taken on different days. There are several blood tests fo...
https://www.mayoclinic.org/diseases-conditions/type-2-diabetes-in-children/symptoms-causes/syc-20355318
Aug 25th, 2020 - Overview Type 2 diabetes in children is a chronic disease that affects the way your child's body processes sugar (glucose). Without treatment, the disorder causes sugar to build up in the blood, which can lead to serious long-term consequences. Ty...
News 49 results
https://www.medscape.com/viewarticle/945406
Feb 7th, 2021 - NEW YORK (Reuters Health) - The first genome-wide association study (GWAS) of type 2 diabetes in young people identified genes already known in adults as well as novel variants, researchers say. "This suggests that type 2 diabetes in children has ...
https://www.mdedge.com/pediatrics/article/214278/diabetes/could-liraglutide-stall-onset-type-2-diabetes-children?channel=39313
Doug Brunk
Dec 13th, 2019 - LOS ANGELES – Until the recent approval of liraglutide for the treatment of children and adolescents with type 2 diabetes, investigators like Sonia Caprio, MD, were at their wits’ end watching the beta-cell function of their patients decline on me.
http://care.diabetesjournals.org/content/42/Supplement_1/S148
Dec 18th, 2018 - The management of diabetes in children and adolescents cannot simply be derived from care routinely provided to adults with diabetes. The epidemiology, pathophysiology, developmental considerations, and response to therapy in pediatric-onset diabe...
http://care.diabetesjournals.org/content/42/Supplement_1/S13
Dec 18th, 2018 - Type 1 diabetes and type 2 diabetes are heterogeneous diseases in which clinical presentation and disease progression may vary considerably. Classification is important for determining therapy, but some individuals cannot be clearly classified as ...
http://care.diabetesjournals.org/content/42/Supplement_1/S7
Dec 18th, 2018 - Population health is defined as “the health outcomes of a group of individuals, including the distribution of health outcomes within the group”; these outcomes can be measured in terms of health outcomes (mortality, morbidity, health, and function...